MENU

FOLD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Amicus Therapeutics (FOLD) Ownership - Who owns Amicus Therapeutics?

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

47 Hulfish Street

Phone

+1 609 662-2000

Employees

511

Web

https://www.amicusrx.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

4.55B

P/E Ratio

N/A

Total Cash

293.54M

Projected Growth

N/A

Total Debt

442.36M

Revenue

634.21M

Risk (Beta)

0.53

Dividend Yield

N/A

Total Cash/Share

0.93

Total Debt/Equity

46.37

Revenue/Share

2.06 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for FOLD

A.I. Advisor

published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

47 Hulfish Street

Phone

+1 609 662-2000

Employees

511

Web

https://www.amicusrx.com